Psoriatic arthritis: why assessment comes before PRP

Evidence checked in November 2026. General information from The Wellness Team.

Joint swelling, morning stiffness or a swollen finger in someone with psoriasis deserves a diagnosis before an injection is chosen. Psoriatic arthritis is an inflammatory condition in which the immune system affects joints and related tissues. Its management is different from treatment for a mechanically painful tendon or osteoarthritis.

Platelet-rich plasma, or PRP, should not replace assessment for suspected inflammatory arthritis or the treatment prescribed by a rheumatologist. The priority is to identify active inflammation and establish a plan that protects long-term joint function. That remains important even when the immediate concern is just one painful knee, heel or finger.

Discuss joint symptoms before considering a PRP treatment.

A clinician reviewing notes during a consultation.

Illustrative photograph from the existing image library. Treatment depends on the diagnosis and individual assessment.

Symptoms that change the treatment discussion

Psoriatic arthritis can cause pain, swelling and stiffness in one or more joints. Fingers or toes may become diffusely swollen, and nails may develop pits or other changes. Symptoms can be worse first thing in the morning and improve with movement. Fatigue may accompany the joint symptoms.

Pain where a tendon attaches to bone, known as enthesitis, can also be relevant. A heel that remains painful without a clear mechanical explanation is not automatically a tendon injury suitable for an injection. The history of psoriasis, other symptoms and examination can change the interpretation.

Not everyone with psoriasis develops psoriatic arthritis, and not every painful joint in someone with psoriasis is caused by it. Osteoarthritis, gout and other conditions can produce overlapping symptoms. Equally, the NHS advises assessment for recurrent joint pain, swelling and stiffness even when a person does not have psoriasis.

Why rheumatology assessment matters

NICE recommends urgent referral for suspected new-onset inflammatory arthritis within its spondyloarthritis pathway, with appropriate alternative pathways when another inflammatory condition is suspected. It also recommends rheumatology assessment for dactylitis, the diffuse swelling of a finger or toe, and for certain patterns of unexplained enthesitis.

The purpose is to clarify the diagnosis and choose appropriate treatment, rather than allow a sequence of local procedures to delay assessment of the underlying disease. Treating pain in one location is not the same as controlling inflammatory disease throughout the body.

A GP can begin the history and examination and arrange the appropriate referral. Tests may include blood tests, imaging or analysis of joint fluid according to the clinical question. None is a universal substitute for specialist judgement.

Normal blood tests do not close the question

NICE states that normal inflammatory markers, including CRP and ESR, do not rule out spondyloarthritis. This matters when symptoms suggest inflammation but a previous blood panel was described as reassuring.

A scan can also be useful without being decisive on its own. The location of inflammation, the pattern of symptoms, skin and nail findings, examination and test results need to be considered together. An isolated finding labelled wear and tear does not necessarily explain every symptom.

A screening questionnaire may support a referral discussion, but it cannot confirm or exclude psoriatic arthritis. The assessment should remain open to the whole clinical picture rather than turn into a checklist that gives false certainty.

Enquire about an assessment-led discussion of joint symptoms.

What established treatment aims to do

Medicines are the main treatment for psoriatic arthritis. Depending on severity and response, a rheumatologist may use disease-modifying anti-rheumatic drugs or biological treatment, alongside other measures. Physiotherapy and occupational therapy can support movement, function and practical adjustments.

Some treatments help symptoms; others are selected to control the underlying inflammatory disease. Those roles should not be blurred. A local intervention that temporarily improves pain is not evidence that the disease has been controlled or that long-term medication is no longer needed.

Do not stop prescribed treatment, including immune-modifying medicines, to prepare for a PRP procedure without advice from the responsible clinician. Generic preparation instructions cannot account for the risk of a flare or the reason a medicine is being used.

What is known about PRP in psoriatic arthritis?

The direct clinical evidence is limited. A 2023 review of PRP in rheumatic diseases described substantial evidence gaps and variation in preparations and treatment methods. Its search did not identify information about PRP for psoriatic arthritis. That is a statement about that review's search, not proof that no report has ever been published.

A separate 2023 case report described improvement after PRP for knee synovitis in one person with psoriatic arthritis. A single case can suggest a question for future research, but it cannot establish effectiveness, safety across a wider population, the best preparation or the duration of benefit.

Evidence about PRP for osteoarthritis or psoriasis affecting the skin cannot be assumed to apply to inflammatory joint disease. Nor does an explanation involving growth factors establish that an injection can replace a disease-modifying treatment.

These limits do not require claiming that PRP could never have a role. They do mean that it should not be presented as an established routine treatment for psoriatic arthritis, a cure or a proven route to avoiding standard care.

If osteoarthritis or a tendon problem is also present

A person can have more than one cause of musculoskeletal pain. If a separate condition is suspected, the proposed treatment still needs a diagnosis-specific evidence discussion and coordination with the clinician managing the inflammatory disease.

The location and activity of psoriasis, current medicines, infection concerns and the planned injection site may all be relevant to procedural safety. An individual assessment is needed. This article does not confirm that a particular injection is suitable or available.

The useful decision is whether a proposed procedure addresses the identified problem, with an expected benefit that justifies its risks and uncertainty. That may lead to a different treatment, specialist advice or no injection at all.

Symptoms that should not wait for an elective treatment discussion

Eye pain, redness, light sensitivity or blurred vision can indicate inflammation requiring urgent assessment. NICE recommends immediate same-day ophthalmological assessment for symptoms suggesting acute anterior uveitis. Do not wait for a joint consultation if these symptoms occur.

Sudden severe joint pain, swelling or difficulty moving a joint needs urgent GP or NHS 111 assessment. Fever or feeling unwell adds concern, but a fever is not always present with a joint infection. An established diagnosis of arthritis does not make every new episode a routine flare.

A clear plan before a procedure

A good assessment can identify when rheumatology care should come first and when a separate mechanical problem may be considered on its own merits. It should explain the uncertainty and avoid promises that outrun the evidence.

The London PRP Clinic can receive an initial enquiry about assessment and suitability. If the history suggests inflammatory arthritis, the appropriate clinical pathway takes priority over booking PRP. The aim is to protect joint health while choosing care for the right condition.

Discuss suitability and the appropriate next step before booking PRP.

Frequently asked questions

Does psoriasis mean my joint pain is psoriatic arthritis?

No. Several conditions can cause joint pain, including osteoarthritis and gout. Recurrent swelling, stiffness or other inflammatory features warrant assessment to identify the cause.

Can I have psoriatic arthritis without obvious psoriasis?

A lack of obvious psoriasis should not be used to dismiss persistent joint symptoms. The NHS advises assessment for recurrent joint pain, stiffness and swelling even when psoriasis is not present.

Do normal CRP and ESR results rule it out?

No. NICE advises that normal inflammatory markers do not rule out spondyloarthritis. Results must be considered alongside the symptoms and examination.

Is PRP an established treatment for psoriatic arthritis?

No. Direct evidence is limited, including an isolated case report. This does not establish routine effectiveness, long-term safety or replacement of rheumatology treatment.

Should I stop arthritis medicines before PRP?

Do not stop prescribed treatment on the basis of general preparation advice. Any change needs agreement from the clinician responsible for the medicine, taking disease control and procedural risks into account.

What should happen before an injection is considered?

The diagnosis and disease activity should be assessed first. Suspected inflammatory arthritis needs an appropriate referral, while any separate mechanical condition requires its own evidence and suitability discussion.

Enquire about an assessment-first approach.

Evidence and further reading

This is general information, not a diagnosis or an individual treatment plan.

Previous
Previous

Vitamin A excess and hair loss: review before PRP

Next
Next

Cubital tunnel symptoms: assessment before PRP